icad inc. (ICAD) news stock charts
icad inc. (ICAD) Investment Summary:
iCAD was founded in 1984 as Howtek, Inc. (“Howtek”). Howtek developed, manufactured and marketed digitizing systems, also referred to as scanners. The scanners converted printed, photographic and other hard copy images to digital form for use in the graphic arts, photo finishing and medical industries. In 1987 Howtek began development of its first scanner with the goals of delivering a smaller, easier to use and less costly alternative to traditional scanners on the market at that time. Howtek followed with a series of products further improving the quality of digital imaging while reducing the price and complexity of digitizing systems. In 2001, foreseeing a decline in the graphic arts and photo finishing industries, the Company elected to focus its efforts solely on the medical imaging industry with increased product offerings. This goal was advanced in June 2002 with the Company’s acquisition of Intelligent Systems Software, Inc. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f17%2f0001144204-08-015886.html#FIS_BUSINESS"ICAD INC (ICAD:NASDAQ)
Snapshot of ICAD INC (ICAD)
|
OPEN
$1.40
|
PREVIOUS CLOSE
$1.40
|
|
|
DAY HIGH
$1.43
|
DAY LOW
$1.39
|
|
|
52 WEEK HIGH
09/24/09 - $2.43
|
52 WEEK LOW
03/20/09 - $0.85
|
|
|
MARKET CAP
65.3M
|
AVERAGE VOLUME 10 D
100.4K
|
|
|
EPS TTM
$-0.04
|
SHARES OUTSTANDING
45.7M
|
|
|
ICAD Does Not Pay Dividends
|
P/E TTM
--
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for ICAD INC (ICAD)
icad Inc. reported consolidated earnings results for the fourth quarter and full year ended December 31, 2009. For the quarter, the company reported revenue of $8,108,110, income from operations of $290,267, net income before provision for income taxes of $311,398, net income of $317,398 or $0.01 per basic and diluted share compared to revenue of $9,316,411, income from operations of $323,155, net income before provision for income taxes of $358,869, net income of $320,869 or $0.01 per basic and diluted share over the same period last year. Total revenue represents a decrease of 13% compared with the fourth quarter of 2008. This reflects a 12% decline in revenue from the company's digital and MRI CAD products to $5.6 million from $6.3 million in the prior year as purchases of capital equipment by U.S. hospitals remained soft comparatively and were somewhat offset by purchases of the company's newer MRI CAD products. International revenue increased 42% to $948,000 from $669,000 in the fourth quarter of 2008. For the full year, the company reported revenue of $28,109,265, loss from operations of $2,120,966, net loss before provision for benefit taxes of $2,011,194, net loss of $1,967,624 or $0.04 per basic and diluted share compared to revenue of $37,491,548, income from operations of $4,765,789, net income before provision for income taxes of $4,591,189, net income of $4,356,189 or $0.10 per basic and diluted share over the same period last year. The company generated positive cash flow in the face of macroeconomic challenges. Total revenue was down 25% from the year ago period.
icad Inc. announced that they will report Q4, 2009 results after the market closes on February 22, 2010.
icad Inc., Q4 2009 Earnings Call, Feb 23 2010
icad inc. financial resources
ICAD Competitors
| Company | Last | Change |
| Guardian Technologies International | $0.12 USD | +0.003 |
| Medipattern Corp/The | C$0.12 CAD | +0.005 |
| Merge Healthcare Inc | $2.26 USD | +0.02 |
| Mevis Medical Solutions AG | €21.75 EUR | +0.75 |
| MGT Capital Investments Inc | $0.24 USD | -0.011 |
| Market data is delayed at least 15 minutes. | ||
Industry Analysis
| Valuation | ICAD | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 2.3x |
|
| Price/Book | 1.0x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 1.7x |
|
|
ICAD |
||
ICAD transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About icad inc.
iCAD Granted U.S. Patent on CAD Lesion Metrics That Enhance Clinical Information for Image Analysis Solutions
Read article
iCAD Announces Schedule of Events and Featured Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the 2010 ECR
Read article
iCAD Takes Leadership Position in Meeting the Need for Accredited Educational Initiatives on Prostate and Breast MRI Imaging Technologies
Read article
iCAD Takes Leadership Position in Meeting the Need for Accredited Educational Initiatives on Prostate and Breast MRI Imaging Technologies
Read article
iCAD Granted U.S. Patent on CAD Lesion Metrics That Enhance Clinical Information for Image Analysis Solutions
Read article
iCAD Announces Schedule of Events and Featured Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the 2010 ECR
Read article
ICAD INC Files SEC form 8-K, Results of Operations and Financial Condition
Read article
iCAD To Host Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call on Tuesday, February 23, 2010
Read article
iCAD To Host Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call on Tuesday, February 23, 2010
Read article
ICAD INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Read article
iCAD Announces Schedule of Events and Featured Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the 2009 RSNA
Read article
iCAD Announces Partnership with AdMeTech Foundation to Facilitate Advancement of Imaging Technologies for Improved Diagnosis of Prostate Cancer
Read article
ICAD INC Files SEC form 8-K, Change in Directors or Principal Officers
Read article